Institute for Health Metrics and Evaluation (IHME)

11/23/2025

Diabetes, obesity, and high blood pressure remain the top drivers of chronic kidney disease (CKD), alongside dietary risks and environmental factors.

A recent study published in The Lancet identified 14 detailed risk factors for CKD, with diabetes, high blood pressure, and obesity driving the greatest loss of healthy years of life. Dietary factors, such as low fruit and vegetable intake and high sodium consumption, also made substantial contributions.

Read the research: http://ms.spr.ly/6189tPHb7

11/22/2025

Headache disorders affected almost 3 billion people worldwide in 2023 — nearly one in every three people. New research found there has been no meaningful change in headache disorder burden over the last 30 years, suggesting that the root causes remain untouched.

Yvonne Xu, co-author and research scientist at IHME, discusses the key findings in a Q&A video: http://ms.spr.ly/6185tTg7d

11/21/2025

The rising prevalence of obesity and diabetes, together with global population aging, is driving a growing burden of chronic kidney disease (CKD), according to a recent study published in The Lancet.

In 2023, most people with CKD were in the early stages of the disease (stages 1–3). Expanding access to diagnosis and affordable care, addressing risk factors, and prioritizing screening programs and risk-reducing strategies can help combat rising global CKD trends → http://ms.spr.ly/6185tPHEB

11/20/2025

There were higher mortality rates in sub-Saharan Africa among women and children than previously estimated, according to findings from the Global Burden of Disease 2023 study.

Mortality among children (aged 5–14) in sub-Saharan Africa was 87% higher overall and death rates among younger females (aged 15–29) were more than 60% greater than past studies estimated.

IHME experts explain how innovations in the research methods prompted these changes: http://ms.spr.ly/6180tTdHp

11/19/2025

Join IHME on November 25 at 7 a.m. PT for London Global Cancer Week. Learn more about the new Global Burden of Disease estimates from 1990 to 2023 and forecasts through 2050 and discuss how to apply these findings toward program and policy goals that reduce cancer burden.

Register for the session: http://ms.spr.ly/6188troYk

11/18/2025

How have headache disorders influenced global health loss and disability? A new study from researchers at the NTNU - Norges teknisk-naturvitenskapelige universitet and IHME examined the global burden of headache disorders and found they are one of the most common and disabling health conditions.

In 2023, headache disorders accounted for an age-standardized rate of 541.9 years lived with disability (YLDs) per 100,000 people, ranking sixth among all causes of disability globally.

Read the research: http://ms.spr.ly/6185tREuD

11/18/2025

Discuss the differences in health outcomes between the s*xes (disparities in disease prevalence, mortality, and disability) according to the latest data from GBD 2023 in upcoming webinars with IHME’s Dr. Luisa Sorio Flor.

Understand emerging trends, persistent gaps, and implications for public health policy, research, and gender-sensitive health care strategies. Learn how to use the GBD Compare: S*x Differences tool to explore GBD estimates related to s*x differences: http://ms.spr.ly/6182tRFvM

Register for an upcoming session ↓
• Monday, December 1, 12:00–1:30 p.m. PT: http://ms.spr.ly/6189tRFvT
• Thursday, December 4, 7–8:30 a.m. PT: http://ms.spr.ly/6180tRFvp
• Tuesday, December 9, 7–8:30 p.m. PT: http://ms.spr.ly/6181tRFvV

11/17/2025

The latest update from IHME’s Financing Global Health report on development assistance for health (DAH) incorporates new data on official development assistance from recently released budget documents of the major bilateral donors and updated listing of terminated USAID awards.

The results suggest that DAH is set to decrease even more than previously estimated, falling from $49.6 billion in 2024 to an estimated $36.2 billion in 2025. We also estimate total DAH provided will remain relatively flat to $35.1 billion in 2030.

Explore the updated data visualization tool: http://ms.spr.ly/6046tRDXk

Download updated estimates ↓
• Development Assistance for Health Database 1990-2025, 14 November 2025 – http://ms.spr.ly/6047tRDXZ

• Global Expected Health Spending 2023-2050, 14 November 2025 – http://ms.spr.ly/6048tRDXw

11/16/2025

Chronic kidney disease (CKD) is a major risk factor for cardiovascular mortality. In 2023, kidney dysfunction accounted for almost 12% of global cardiovascular deaths, ranking seventh among risk factors for cardiovascular mortality, ahead of diabetes and obesity.

New research on the global burden of CKD examined trends in adults aged 20+ across 204 countries from 1990 to 2023.

Read the research, published in The Lancet: http://ms.spr.ly/6180tPDMw

11/15/2025

“Data has shown that when we ignore the mouth, we’re ignoring our body. And that is why we are advocating for the mouth not to be silenced anymore.” – Dr. Adekemi Adeniyan, oral health care advocate and rural dentist, IHME's 2025 Roux Prize recipient.

She has made strides in rural Nigeria as a practicing dentist and Executive Director of the Dentalcare Foundation, where she led the deployment of mobile dental clinics and Nigeria’s first solar-powered tele-dental kiosk, delivering care to over 100,000 people.

Learn more about Dr. Adeniyan's work in this year's Roux Prize video:

Dr. Adekemi Adeniyan, Executive Director of the Dentalcare Foundation, rural dentist, and advocate for oral health advancement in Nigeria, has been named IHM...

11/14/2025

How can we leverage Global Burden of Disease study estimates to improve cancer outcomes for people around the world?

Join us on November 25 at 7 a.m. PT / 10 a.m. ET / 3 p.m. UK for London Global Cancer Week to learn more about the new Global Burden of Disease estimates from 1990 to 2023 and forecasts through 2050 and discuss how to apply these findings toward program and policy goals that reduce cancer burden.

Register for the session ➔ http://ms.spr.ly/6187tOcA5

11/14/2025

Nearly 1 in 3 individuals were affected by headache disorders in 2023 — a total of 3 billion people around the world.

More than one-fifth of the global headache burden was linked to pain medication overuse highlighting major opportunities for safer pain management and improved access to care, according to a new study from IHME and the NTNU - Norges teknisk-naturvitenskapelige universitet published in The Lancet Neurology.

Read the research: http://ms.spr.ly/6188tOcYQ